{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:40:29Z","timestamp":1762864829902},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1093\/jac\/dkh445","type":"journal-article","created":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T20:24:34Z","timestamp":1097180674000},"page":"944-951","source":"Crossref","is-referenced-by-count":14,"title":["In vitro activity of ertapenem against selected respiratory pathogens"],"prefix":"10.1093","volume":"54","author":[{"given":"A.","family":"Marchese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gualco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Schito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Debbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. C.","family":"Schito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,11]]},"reference":[{"key":"key\n\t\t\t\t20171010182812_R1","doi-asserted-by":"crossref","unstructured":"Fauci, A. S. (2001). Infectious diseases: considerations for the 21st century. Clinical Infectious Diseases32, 675\u201385.","DOI":"10.1086\/319235"},{"key":"key\n\t\t\t\t20171010182812_R2","doi-asserted-by":"crossref","unstructured":"Mandell, L. A., Bartlett, J. G., Dowell, S. F. et al. (2003). Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases37, 1405\u201333.","DOI":"10.1086\/380488"},{"key":"key\n\t\t\t\t20171010182812_R3","unstructured":"Felmingham, D. (2002). Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. Journal of Infection44, Suppl. A, 3\u201310."},{"key":"key\n\t\t\t\t20171010182812_R4","unstructured":"National Committee for Clinical Laboratory Standards. (2004). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Sixth Edition: Approved Standard M7-A6 and M100-S14. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010182812_R5","unstructured":"National Committee for Clinical Laboratory Standards. (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline M26-A. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010182812_R6","doi-asserted-by":"crossref","unstructured":"Livermore, D. M., Sefton, A. M. & Scott, G. M. (2003). Properties and potential of ertapenem. Journal of Antimicrobial Chemotherapy52, 331\u201344.","DOI":"10.1093\/jac\/dkg375"},{"key":"key\n\t\t\t\t20171010182812_R7","doi-asserted-by":"crossref","unstructured":"Jones, R. N. (2001). In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains. Journal of Chemotherapy13, 363\u201376.","DOI":"10.1179\/joc.2001.13.4.363"},{"key":"key\n\t\t\t\t20171010182812_R8","doi-asserted-by":"crossref","unstructured":"Pankuch, G. A., Davies, T. A., Jacobs, M. R. et al. (2002). Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents. Antimicrobial Agents and Chemotherapy46, 42\u20136.","DOI":"10.1128\/AAC.46.1.42-46.2002"},{"key":"key\n\t\t\t\t20171010182812_R9","doi-asserted-by":"crossref","unstructured":"Ortiz-Ruiz, G., Vetter, N., Isaacs, R. et al. (2004). Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies. Journal of Antimicrobial Chemotherapy53, Suppl. S2, ii59\u201366.","DOI":"10.1093\/jac\/dkh207"},{"key":"key\n\t\t\t\t20171010182812_R10","doi-asserted-by":"crossref","unstructured":"Marchese, A., Mannelli, S., Tonoli, E. et al. (2001). Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997\u20131999). Microbial Drug Resistance7, 277\u201387.","DOI":"10.1089\/10766290152652837"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/5\/944\/2429683\/dkh445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:55:40Z","timestamp":1507668940000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/5\/944\/812029\/In-vitro-activity-of-ertapenem-against-selected"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,11]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh445","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}